Literature DB >> 12093177

Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East.

Robert S Lanciotti1, Gregory D Ebel, Vincent Deubel, Amy J Kerst, Severine Murri, Richard Meyer, Michael Bowen, Nancy McKinney, William E Morrill, Mary B Crabtree, Laura D Kramer, John T Roehrig.   

Abstract

The complete nucleotide sequences of eight West Nile (WN) virus strains (Egypt 1951, Romania 1996-MQ, Italy 1998-equine, New York 1999-equine, MD 2000-crow265, NJ 2000MQ5488, NY 2000-grouse3282, and NY 2000-crow3356) were determined. Phylogenetic trees were constructed from the aligned nucleotide sequences of these eight viruses along with all other previously published complete WN virus genome sequences. The phylogenetic trees revealed the presence of two genetic lineages of WN viruses. Lineage 1 WN viruses have been isolated from the northeastern United States, Europe, Israel, Africa, India, Russia, and Australia. Lineage 2 WN viruses have been isolated only in sub-Saharan Africa and Madagascar. Lineage 1 viruses can be further subdivided into three monophyletic clades. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh：

Year:  2002        PMID： 12093177     DOI： 10.1006/viro.2002.1449

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


  146 in total

1.  Nonconsensus West Nile virus genomes arising during mosquito infection suppress pathogenesis and modulate virus fitness in vivo.

Authors:  Gregory D Ebel; Kelly A Fitzpatrick; Pei-Yin Lim; Corey J Bennett; Eleanor R Deardorff; Greta V S Jerzak; Laura D Kramer; Yangsheng Zhou; Pei-Yong Shi; Kristen A Bernard
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus.

Authors:  Roy A Hall; Debra J Nisbet; Kim B Pham; Alyssa T Pyke; Greg A Smith; Alexander A Khromykh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-13       Impact factor: 11.205

3.  Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence.

Authors:  Brian C Keller; Brenda L Fredericksen; Melanie A Samuel; Richard E Mock; Peter W Mason; Michael S Diamond; Michael Gale
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Inhibitor of κB kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection.

Authors:  Olivia Perwitasari; Hyelim Cho; Michael S Diamond; Michael Gale
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

5.  Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge.

Authors:  Orly Gershoni-Yahalom; Shimon Landes; Smadar Kleiman-Shoval; David Ben-Nathan; Michal Kam; Bat-El Lachmi; Yevgeny Khinich; Michael Simanov; Itzhak Samina; Anat Eitan; Irun R Cohen; Bracha Rager-Zisman; Angel Porgador
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

6.  Characterization of a West Nile virus isolate from a human on the Gulf Coast of Texas.

Authors:  Bruno P Granwehr; Li Li; Charles T Davis; David W C Beasley; Alan D T Barrett
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

Review 7.  Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

8.  Temporal analyses of the neuropathogenesis of a West Nile virus infection in mice.

Authors:  Elizabeth A Hunsperger; John T Roehrig
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

9.  A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice.

Authors:  Amelia K Pinto; Justin M Richner; Elizabeth A Poore; Pradnya P Patil; Ian J Amanna; Mark K Slifka; Michael S Diamond
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

10.  Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses.

Authors:  Eva Lee; Roy A Hall; Mario Lobigs
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.